Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease

AIMS/INTRODUCTION: The objective of the present study was to elucidate the effect of switching to teneligliptin from other dipeptidyl peptidase‐4 (DPP‐4) inhibitors on glucose control and renoprotection in type 2 diabetes mellitus patients with diabetic kidney disease. MATERIALS AND METHODS: The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitada, Munehiro, Ogura, Yoshio, Nitta, Kyoko, Fujii, Mizue, Kanasaki, Keizo, Konishi, Kazunori, Iida, Yasuo, Nakagawa, Atsushi, Koya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497591/
https://www.ncbi.nlm.nih.gov/pubmed/30136384
http://dx.doi.org/10.1111/jdi.12917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497591/
https://www.ncbi.nlm.nih.gov/pubmed/30136384
http://dx.doi.org/10.1111/jdi.12917

Ejemplares similares